GOLDMAN SACHS GROUP INC - TEVA PHARMACEUTICAL FIN LLC ownership

TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 49 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of TEVA PHARMACEUTICAL FIN LLC
ValueSharesWeighting
Q4 2020$7,216,000
+2.5%
7,252,0000.0%0.00%0.0%
Q3 2020$7,038,000
+0.2%
7,252,0000.0%0.00%0.0%
Q2 2020$7,023,000
-6.9%
7,252,000
-11.0%
0.00%
-33.3%
Q1 2020$7,545,000
-40.9%
8,152,000
-39.5%
0.00%0.0%
Q4 2019$12,766,000
+56.6%
13,467,000
+49.6%
0.00%
+50.0%
Q3 2019$8,153,000
-17.6%
9,004,000
-16.8%
0.00%
-33.3%
Q2 2019$9,894,000
+42.2%
10,820,000
+43.4%
0.00%
+50.0%
Q1 2019$6,958,000
+43.6%
7,547,000
+40.6%
0.00%0.0%
Q4 2018$4,845,000
+654.7%
5,368,000
+632.3%
0.00%
Q1 2018$642,000
-32.5%
733,000
-30.5%
0.00%
Q3 2017$951,000
+112.8%
1,055,000
+153.6%
0.00%
Q1 2017$447,000
-95.3%
416,000
-94.8%
0.00%
-100.0%
Q3 2016$9,515,000
+94.0%
7,975,000
+111.6%
0.00%
+50.0%
Q1 2016$4,904,000
-77.5%
3,769,000
-72.9%
0.00%
-71.4%
Q4 2015$21,750,000
-9.2%
13,931,000
-21.1%
0.01%
-12.5%
Q3 2015$23,953,000
+105.6%
17,661,000
+111.8%
0.01%
+100.0%
Q2 2015$11,652,000
+464.5%
8,338,000
+416.3%
0.00%
+300.0%
Q2 2014$2,064,000
+45.5%
1,615,000
+44.5%
0.00%
Q1 2014$1,419,000
+1026.2%
1,118,000
+839.5%
0.00%
Q4 2013$126,000
-78.0%
119,000
-78.4%
0.00%
Q3 2013$572,000
+64.4%
552,000
+61.9%
0.00%
Q4 2012$348,000
-28.8%
341,000
-26.2%
0.00%
Q3 2012$489,000
+37.7%
462,000
+35.5%
0.00%
Q2 2012$355,000
-13.2%
341,000
-8.3%
0.00%
Q1 2012$409,000372,0000.00%
Other shareholders
TEVA PHARMACEUTICAL FIN LLC shareholders Q3 2020
NameSharesValueWeighting ↓
Radcliffe Capital Management, L.P. 70,783,000$69,363,0006.27%
INCOME RESEARCH & MANAGEMENT 14,978,000$14,536,0005.17%
PIPER SANDLER & CO. 5,000,000$4,852,0003.63%
Western Asset Management Company, LLC 42,946,000$42,102,0003.46%
PenderFund Capital Management Ltd. 4,000,000$5,225,0001.45%
Bracebridge Capital, LLC 5,500,000$5,335,0000.85%
WESTWOOD HOLDINGS GROUP INC 43,185,000$42,490,0000.54%
CORBYN INVESTMENT MANAGEMENT INC/MD 1,025,000$995,0000.52%
LMR Partners LLP 22,235,000$21,742,0000.45%
JUPITER ASSET MANAGEMENT LTD 35,000,000$34,357,0000.36%
View complete list of TEVA PHARMACEUTICAL FIN LLC shareholders